Our Pricing

Mounjaro vs Wegovy vs Saxenda: Which Weight Loss Injection Is Right for You?

Published on: June 03, 2026

Choosing between mounjaro vs wegovy vs saxenda uk options can feel overwhelming, especially with different mechanisms, dosing schedules, and clinical outcomes to consider. At Cured Pharmacy, our UK-registered clinical team helps patients navigate these prescription weight loss treatments with transparent pricing, genuine UK-licensed medications, and expert guidance tailored to your individual health profile.

Understanding the Three Main Injectable Weight Loss Treatments

The UK market now offers three MHRA-licensed injectable weight loss medications, each working through the GLP-1 pathway but with distinct characteristics. Mounjaro (tirzepatide) is the newest option and the only dual GIP/GLP-1 receptor agonist, activating two complementary hormone pathways that regulate appetite and blood glucose [1]. Wegovy (semaglutide) is a single GLP-1 receptor agonist administered once weekly, whilst Saxenda (liraglutide) is an earlier-generation GLP-1 treatment requiring daily injections [2].

Clinical trial data reveals significant differences in efficacy between these treatments. In the SURMOUNT-1 trial, participants taking the highest Mounjaro dose achieved an average weight reduction of 22.5% over 72 weeks [1]. By comparison, the STEP-1 trial showed Wegovy participants lost an average of 14.9% body weight over 68 weeks [2], whilst SCALE trial data for Saxenda demonstrated average weight loss of 8.0% over 56 weeks [3]. These differences reflect both the medications' mechanisms and their dosing protocols.

All three treatments require a prescription from a UK-registered prescriber and are subject to clinical assessment. At Cured Pharmacy, our online consultation process—completed in under three minutes—ensures you receive the most appropriate treatment based on your medical history, current medications, and weight loss goals.

Mounjaro vs Wegovy: Comparing Dual and Single Pathway Treatments

The fundamental difference between Mounjaro and Wegovy lies in their receptor activity. Tirzepatide's dual GIP/GLP-1 action produces more pronounced effects on both appetite suppression and metabolic regulation compared to semaglutide's single-pathway approach [1][4]. This translates to measurably greater weight reduction in head-to-head comparisons, with tirzepatide demonstrating superior efficacy across multiple clinical endpoints.

Both medications follow weekly injection schedules, making them equally convenient for most patients. However, the dose escalation protocols differ slightly: Mounjaro typically starts at 2.5mg weekly and may increase to a maintenance dose of 5mg, 10mg, or 15mg depending on individual response and tolerability [1]. Wegovy begins at 0.25mg weekly and escalates over 16-20 weeks to a maintenance dose of 2.4mg [2]. Your UK prescriber will determine the appropriate starting dose and titration schedule during your clinical assessment.

Side Effect Profiles: What to Expect

Both Mounjaro and Wegovy share similar gastrointestinal side effects due to their GLP-1 activity, including nausea, diarrhoea, constipation, and reduced appetite [1][2]. These effects are typically most pronounced during dose escalation and often diminish as your body adjusts to the medication. Clinical trial data suggests tirzepatide may produce slightly higher rates of nausea at equivalent efficacy levels, though individual tolerance varies considerably [4].

Serious adverse events remain rare with both treatments when prescribed appropriately. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. Your Cured Pharmacy prescriber will review your complete medical history to ensure safe prescribing.

Saxenda vs Mounjaro and Wegovy: Daily vs Weekly Injections

Saxenda's daily injection requirement represents the most significant practical difference when comparing these three treatments. Whilst liraglutide's shorter half-life necessitates daily dosing, this also means the medication clears your system more quickly if you experience side effects or need to discontinue treatment [3]. For patients who prefer weekly administration, Mounjaro or Wegovy may prove more convenient and improve long-term adherence.

Clinical efficacy data clearly favours the newer GLP-1 treatments. Saxenda's average weight loss of 8.0% over 56 weeks [3] is substantially lower than the 14.9% achieved with Wegovy [2] or the 22.5% seen with Mounjaro [1]. However, Saxenda remains a valuable option for patients who may not tolerate higher-potency treatments or who have specific medical considerations that make it the most appropriate choice. The lower starting price point also makes it accessible for those beginning their weight loss journey.

Cost Considerations Across Treatment Options

At Cured Pharmacy, Mounjaro is available from £124.99, reflecting the medication's advanced dual-agonist formulation and superior clinical outcomes. Our transparent pricing model means you'll see the exact cost before completing your consultation, with no hidden fees or surprise charges. We guarantee the lowest prices in the UK for genuine, UK-licensed medications dispensed by our GPhC-registered pharmacy team.

Treatment duration varies by individual, but most patients require ongoing therapy to maintain weight loss results. Your UK prescriber will discuss realistic timelines during your consultation and may recommend periodic reviews to assess progress and adjust treatment as needed. All prescription medications at Cured Pharmacy require clinical assessment—we never dispense prescription-only medicines without proper medical oversight.

Clinical Trial Data: Understanding the Evidence Base

The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight plus weight-related comorbidities, randomising participants to tirzepatide (5mg, 10mg, or 15mg weekly) or placebo [1]. At 72 weeks, the 15mg tirzepatide group achieved mean weight reduction of 22.5% compared to 2.4% in the placebo group—a clinically and statistically significant difference that represents the highest efficacy demonstrated by any approved weight loss medication to date.

The STEP-1 trial for semaglutide followed a similar design with 1,961 participants receiving either Wegovy 2.4mg weekly or placebo [2]. Mean weight loss at 68 weeks reached 14.9% in the semaglutide group versus 2.4% in placebo, establishing Wegovy as a highly effective treatment option. The SCALE trial for liraglutide demonstrated 8.0% mean weight loss at 56 weeks compared to 2.6% with placebo [3], confirming efficacy but at lower magnitude than the newer treatments.

These trials used rigorous methodology including intention-to-treat analysis and appropriate statistical controls. However, clinical trial populations may not perfectly reflect real-world patients, and individual results will vary based on adherence, lifestyle modifications, baseline health status, and genetic factors. Your Cured Pharmacy prescriber can discuss realistic expectations based on your personal circumstances.

Choosing Between Mounjaro vs Wegovy vs Saxenda: Clinical Considerations

Selection of the most appropriate weight loss injection depends on multiple clinical factors beyond efficacy alone. Patients with type 2 diabetes may benefit particularly from tirzepatide's dual-agonist mechanism, which produces superior glycaemic control compared to single GLP-1 agonists [4]. Those with previous GLP-1 experience may tolerate dose escalation differently than treatment-naïve patients, influencing the starting medication choice.

Contraindications and drug interactions require careful evaluation. All three medications are contraindicated in pregnancy, and women of childbearing potential should use reliable contraception during treatment [1][2][3]. Patients taking insulin or sulfonylureas may require dose adjustments to prevent hypoglycaemia when starting GLP-1 therapy. Our UK prescribers at Cured Pharmacy review your complete medication list during the online consultation to identify potential interactions.

Practical factors also influence treatment selection. Some patients strongly prefer weekly over daily injections, whilst others prioritise starting with the lowest-cost option before escalating to higher-potency treatments. Needle phobia, injection site reactions, and lifestyle considerations all play legitimate roles in shared decision-making between patient and prescriber.

When to Consider Alternative Treatments

Injectable GLP-1 medications aren't suitable for everyone. Patients with contraindications, needle phobia, or preference for oral therapy may benefit from alternatives like Wegovy oral tablets (semaglutide pill) or Orlistat, a fat absorption inhibitor available in prescription and over-the-counter formulations. These options work through entirely different mechanisms and carry distinct benefit-risk profiles.

Combination approaches may also prove valuable. Some patients achieve optimal results by pairing pharmacotherapy with structured lifestyle programmes, dietitian support, or psychological interventions addressing emotional eating patterns. Your Cured Pharmacy prescriber can recommend complementary strategies to maximise your weight loss success whilst ensuring safe, evidence-based care.

Getting Started with Weight Loss Treatment at Cured Pharmacy

Beginning your weight loss journey with Cured Pharmacy takes less than three minutes. Our online consultation captures essential medical information including current medications, allergies, previous weight loss attempts, and relevant health conditions. A UK-registered prescriber reviews your submission and determines whether Mounjaro, Wegovy, Saxenda, or an alternative treatment is most appropriate for your individual circumstances.

If approved, we dispense your medication from our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). All medications are genuine UK-licensed products—we never supply unlicensed or imported alternatives. Discreet packaging ensures your privacy, and our clinical team remains available to answer questions throughout your treatment journey.

Follow-up care is essential for safe, effective weight loss treatment. We recommend regular check-ins with your prescriber to monitor progress, adjust dosing if needed, and address any side effects promptly. Sustainable weight loss requires ongoing commitment to both medication adherence and lifestyle modifications including balanced nutrition and regular physical activity. Our team supports you at every stage of this process with expert guidance grounded in current UK clinical practice.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence, lifestyle modifications, and baseline health status.